Trader logo

Alexander Frolov Target Global Co-Founder and Technology Investor

Technology Investor

By NaveedPublished 9 days ago • 6 min read

Description: Alexander Alexandrovich Frolov: business profile, co-founder role at Target Global, early-stage investment focus, Palta, Flo Health, and technology portfolio experience.

Alexander Frolov: Target Global Co-Founder and Technology Investor

Alexander Alexandrovich Frolov is a co-founder of Target Global and a technology investor focused mainly on early-stage companies. His work combines two roles: evaluating businesses as an investor and taking a more direct part in building new projects.

This combination is important to his profile. Frolov works with companies before their products, teams, and business models are fully established. His background helps explain how he approaches this stage and why his work extends beyond investment decisions alone.

Alexander Alexandrovich Frolov: education and business background

Frolov studied Economics at the London School of Economics and later earned an MBA from London Business School. There, he learned about markets and financial analysis combined with practical training in management, strategy, and business development.

He applied this background to technology investment and company building.

Frolov co-founded Target Global in 2012. The firm invests in technology companies at different stages of development and supports them as they expand internationally.

He has also led strategic projects and co-founded companies, including Palta, a health technology company built around preventive care and wellbeing.

That side of his work sits between investing and operating. The decisions are concrete ones: what to build next, how the team grows, which market to open.

Alexander Frolov Target Global and the early-stage approach

Target Global invests in technology companies across several markets. Its portfolio and investment history includes companies such as Revolut, Rapyd, Finom, Copper, Delivery Hero, AUTO1 Group, Fresha, Docplanner, Robovision, and Voyantis.

The companies differ in market and stage, but the questions asked at the point of investment are similar:

Does the company solve a clear and recurring problem?

Do users return because the product delivers lasting value?

Can the team learn from data and respond to market feedback?

Is the business model suitable for international expansion?

Can the company maintain quality and trust as it grows?

Early-stage work puts those questions under pressure. The company is still flexible, which is useful. It can change the product, narrow the market, adjust pricing, improve onboarding, or rebuild parts of the team. The same flexibility also creates risk. A young company can move quickly in the wrong direction.

The early-stage focus associated with the Alexander Frolov Target Global profile is therefore less about chasing a fashionable sector and more about reading early evidence.

A promising market is not enough. The product has to solve a frequent problem, the team has to learn quickly, and the business has to show signs that it can handle a larger operating environment.

Portfolio areas behind the profile

Each area of Target Global's portfolio and investment history presents a distinct operating challenge and contributes to a broader understanding of how digital products develop.

Area

Portfolio examples

Core product question

Fintech

Revolut, Rapyd, Finom, Copper

Can financial services become simpler, safer, and easier to use across markets?

Healthtech

Doctorly, Docplanner

Can a product earn trust in personal and recurring health scenarios?

Business software and AI

Robovision, Voyantis, Ermetic, Demodesk

Can software remove manual work and improve decisions inside companies?

Mobility and marketplaces

AUTO1 Group, Delivery Hero, Fresha

Can a platform balance supply, demand, service quality, and repeat use?

Frolov’s cross-sector experience provides a basis for comparing companies with very different products.

Fintech emphasizes security, reliability, and clarity. Healthtech makes privacy, credibility, and tone central to the user experience. Marketplaces demonstrate how difficult it is to balance participants while maintaining service quality.

Business software and AI face another test. A product may look impressive in a demonstration, but companies continue using it only when it saves time, improves decisions, or removes persistent friction.

Across these areas, the Alexander Frolov Target Global investment focus remains connected with product relevance, strong teams, measurable demand, and the ability to expand responsibly.

Palta as a digital health company-building project

Palta is one of the clearest examples of Frolov’s work with strategic projects. Instead of just developing a single application, it builds and supports a wide range of consumer products focused on health and wellbeing.

Palta's products include Flo and Simple. As of its own reporting in 2026, the company says it has 420 million downloads and 77 million monthly active users.

What connects these products is their operating model. They are designed for recurring use, rely on direct relationships with consumers, and need to adapt to audiences in different markets.

By bringing them together, Palta can apply shared experience in product development, subscriptions, user growth, and international expansion while keeping each brand focused on its own audience.

For Frolov, Palta demonstrates what company building looks like in practice. His involvement is not limited to selecting an existing business for investment. It includes helping create a structure capable of developing and scaling several technology products.

Flo Health illustrates the scale an individual product within this structure can achieve.

Flo Health and product scale

Flo Health is the most visible company in the Palta ecosystem. The product began as a cycle-tracking app and expanded into a broader platform for different stages of female health.

Flo describes itself as the world’s most popular female health app.

The company says it has 420 million downloads and 77 million monthly active users. In a consumer category, those figures would already be notable. In women’s health, they carry another meaning: users are trusting the product with personal information, private routines, and health-related questions.

Downloads show reach, while retention shows whether the service has become useful.

The project’s scale comes from a recurring use case. Menstruation, conception, pregnancy, perimenopause, and hormonal health are not one-time needs. They require clarity, continuity, and a calm product experience.

Flo Health is part of Target Global's investment history, and it combines consumer scale with trust, data, content, and interface design. A weak link in one area can affect the whole experience.

What defines Frolov’s technology investor profile

The companies in Target Global's portfolio and investment history work in different industries, but several principles run through them:

  • Product judgment. The company must solve a problem users encounter repeatedly.

  • Team quality. Early-stage progress depends on how fast the team learns and acts.

  • Trust. Fintech, healthtech, and AI products need credibility before they can scale.

  • International readiness. The product should be built with future markets in mind.

  • Focus. A crowded roadmap can weaken a young company before the market has responded.

Continuity. Strategic projects such as Palta sit alongside his work at the firm.

These points keep the profile tied to operating reality. A technology investor’s work is visible not only in company names, but in the kinds of problems those companies solve and the decisions that help them mature.

Current role in short answers

What is Frolov's role at Target Global?

Frolov co-founded Target Global in 2012. At the firm he works on strategic projects and co-founding initiatives, including Palta.

How does Palta fit into that role?

Palta adds a digital health layer to Frolov’s current work: company building, product judgment, consumer trust, and preventative health and wellbeing products.

Why does the current role matter for the profile?

It shows how the experience is being applied now: which products need strategic support, which teams are being built, and where early-stage decisions can still shape a company before its model becomes fixed.

Conclusion

The Alexander Frolov Target Global investment profile combines early-stage investing, strategic company building, and experience across multiple technology sectors. Its central theme is the assessment of products and teams at a point when informed decisions can still influence a company’s direction.

Alexander Alexandrovich Frolov applies this approach through a focus on product relevance, team quality, user trust, measurable value, and international readiness. Palta and Flo Health provide the clearest examples of how these principles can be applied in digital health.

Together, these projects show how recurring customer needs, responsible product design, and a focused operating strategy can help a technology company move from an early concept toward sustainable international growth.

economy

About the Creator

Naveed

Naveed is an independent journalist and tech writer covering AI, emerging innovations, and digital transformation, exploring how technology shapes business and society.

Enjoyed the story? Support the Creator.

Subscribe for free to receive all their stories in your feed.

Subscribe For Free

Reader insights

Comments

There are no comments for this story

Be the first to respond and start the conversation.

Sign in to comment
    Written by Naveed